Pentoxifylline does not prevent microvascular injury in normotensive, septic rats

Crit Care Med. 1995 Jan;23(1):119-24. doi: 10.1097/00003246-199501000-00020.

Abstract

Objective: To determine if treatment with pentoxifylline would decrease the tissue injury that occurs in a normotensive model of sepsis.

Design: Random assignment to control, cecal ligation-perforation, or cecal ligation-perforation plus pentoxifylline groups for a 24-hr study.

Setting: Animal laboratory.

Subjects: Male Sprague-Dawley rats.

Interventions: Sepsis was induced by cecal ligation-perforation with aggressive fluid resuscitation (normal saline 10 mL/kg/hr). Pentoxifylline was administered as a 2-mg/kg bolus, followed by a continuous infusion of 6 mg/kg/hr.

Measurements and main results: Compared with controls, rats in the cecal ligation-perforation group had an increased heart rate (432 +/- 12 vs. 399 +/- 10 beats/min) and respiratory rate (129 +/- 6 vs. 94 +/- 7 breaths/min). Blood pressure was slightly decreased (104 +/- 4 vs. 125 +/- 5 mm Hg), while cardiac index was not significantly different (50.1 +/- 5.7 vs. 40.7 +/- 3.9 mL/min/100 g). Blood pressure (103 +/- 4 mm Hg) was the only parameter that was significantly different in the cecal ligation-perforation plus pentoxifylline group compared with controls. When compared with controls, tissue wet/dry weight ratios were increased in the diaphragm of the cecal ligation-perforation group and in the liver, pancreas, small bowel, and large bowel of the cecal ligation-perforation, and the cecal ligation-perforation plus pentoxifylline groups. Tissue/plasma albumin ratios were increased in the diaphragm of the cecal ligation-perforation group and in the liver, pancreas, and large bowel of the cecal ligation-perforation and the cecal ligation-perforation plus pentoxifylline groups. There were no significant differences between the cecal ligation-perforation and the cecal ligation-perforation plus pentoxifylline groups.

Conclusions: Normotensive sepsis is accompanied by increased vascular permeability in the diaphragm and intra-abdominal organs. Pentoxifylline appears to attenuate some of the systemic manifestations of sepsis. However, pentoxifylline did not prevent the development of protein-rich tissue edema.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects*
  • Capillary Permeability / drug effects*
  • Cecum
  • Heart Rate
  • Ligation
  • Male
  • Microcirculation / physiopathology
  • Organ Size
  • Pentoxifylline / pharmacology*
  • Punctures
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Respiration
  • Sepsis / blood
  • Sepsis / drug therapy
  • Sepsis / pathology
  • Sepsis / physiopathology*
  • Serum Albumin / analysis

Substances

  • Serum Albumin
  • Pentoxifylline